GALLEON PHARMACEUTICALS
Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.
GALLEON PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2003-01-01
Address:
Horsham, Pennsylvania, United States
Country:
United States
Website Url:
http://www.galleonpharma.com
Total Employee:
11+
Status:
Closed
Contact:
(267)803-1970
Email Addresses:
[email protected]
Total Funding:
53 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon Virginia Region
Current Advisors List
Founder
Investors List
TPG
TPG investment in Series B - Galleon Pharmaceuticals
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Galleon Pharmaceuticals
BioAdvance
BioAdvance investment in Series B - Galleon Pharmaceuticals
HealthCare Ventures
HealthCare Ventures investment in Series B - Galleon Pharmaceuticals
BioAdvance
BioAdvance investment in Venture Round - Galleon Pharmaceuticals
BioAdvance
BioAdvance investment in Seed Round - Galleon Pharmaceuticals
Official Site Inspections
http://www.galleonpharma.com
- Host name: ec2-54-204-226-176.compute-1.amazonaws.com
- IP address: 54.204.226.176
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Galleon Pharmaceuticals"
Company Summary - Palleon Pharma
Jan 7, 2023 Investors: [email protected]. Title: PowerPoint Presentation Author: Nathan Matt Created Date: 1/7/2023 5:42:55 PM ...See details»
About Us – Palleon Pharmaceuticals
Jim Broderick is an accomplished biotech executive with more than 20 years of experience in the industry. He was Co-Founder and Chairman of Ra Pharmaceuticals (NASDAQ RARX, …See details»
Palleon Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (508)479-6358 Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune …See details»
Palleon Pharmaceuticals: Contact Details and Business Profile
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence …See details»
Palleon Pharmaceuticals - LinkedIn
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence …See details»
Palleon Pharmaceuticals Company Profile | Management and
Find contact information for Palleon Pharmaceuticals. Learn about their Research & Development, Business Services market share, competitors, and Palleon Pharmaceuticals's …See details»
Overview, News & Similar companies - ZoomInfo.com
Palleon Pharmaceuticals contact info: Phone number: (857) 285-5900 Website: www.palleonpharma.com What does Palleon Pharmaceuticals do? Palleon Pharmaceuticals …See details»
Palleon Pharmaceuticals - PitchBook
Palleon Pharmaceuticals General Information Description. Developer of therapeutics designed to offer glycol-immune checkpoint inhibitors to treat cancer. The company's therapeutics are …See details»
Palleon Pharmaceuticals - Craft
Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. The Company’s proprietary Convergence Platform …See details»
Palleon Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.palleonpharma.com. Startups | Holding Company | 2016 | Massachusetts, United States | 10-50 | www.palleonpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ... The …See details»
Palleon Pharmaceuticals Company Overview, Contact Details
[email protected]: [email protected]: 1%. [email protected]: [email protected]: 49%. See more formats. Frequently …See details»
Galleon Pharma - Company Profile - Tracxn
Nov 5, 2024 Galleon Pharma - Pharmaceutical treatment of sleep apnea and related breathing-control disorders. This company is not active anymore. Raised a total funding of $17.5M over …See details»
Palleon Pharma - MassBio
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. The company’s proprietary Convergence …See details»
Palleon Pharmaceuticals Appoints Li Peng, Ph.D., as Chief Scientific ...
WALTHAM, Mass., February 12, 2020 – Palleon Pharmaceuticals, a leading biotech company developing drugs that target the Siglec-Sialoglycan axis to treat cancer, today announced that …See details»
Working At Palleon Pharma: Company Overview and Culture - Zippia
Mar 14, 2024 palleonpharma.com. Organization Type. Private. CEO. Jim Broderick. Social Media. Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer …See details»
Palleon - VentureRadar
Similar Companies: Cue Biopharma USA Publicly Traded Cue Biopharma, a clinical-stage biopharmaceutical company, has rationally engineered a promising new class of injectable …See details»
Palleon Pharmaceuticals Raises $100 million Series B to Develop …
Sep 17, 2020 Learn more at www.palleonpharma.com. Contacts. Nichole Sarkis Ten Bridge Communications [email protected] 774-278-8273 Release Summary.See details»
Palleon Pharmaceuticals Raises $100 million Series B to Develop …
The company has several other drug discovery programs underway in disease areas where glycan-mediated immune regulation plays a role, including inflammatory diseases such as …See details»
Palleon Pharmaceuticals Appoints David Johnson to its Board of ...
WALTHAM, Mass., November 2, 2021 — Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced the …See details»